Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Impact Hub Zürich - Ioannis Tarnanas is Impact Hub Fellow on Healthy Living. frederike asael photography | Facebook
Having nothing then a great idea: Now these startups got the first kick
ألم مترجم آثار ioannis tarnanas award - busneljacka.com
Alzheimer europe virtual museum
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Greek Researcher Receives Top European Innovation Award (video)
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Jan. 14, 2020 - Altoida
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Handbook of Computational Neurodegeneration | SpringerLink
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Greek Researcher Receives Top European Innovation Award
PDF) Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
TOP 100 Swiss Startup Altoida Secures Investment From Hikma Ventures to Drive Better Clinical Outcomes For Brain Disease – Venturelab
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Interview with venture case winner Alterniity: We didn't fly too high or too low”
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas - Worldwebforum
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas on Twitter: "John Baldoni from GSK describing their bold practice of publicing internal trial's datasets at the public domain. An admirable approach and a practice to be replicated! #PrecisionHealth… https://t.co/luozl6YMIO"
Ioannis Tarnanas - Worldwebforum
